New Current Report Filed with the SEC Disclosing Occurrence of a Material Impairment: 8-K – Sagent Pharmaceuticals, Inc. (0001369786) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing the occurrence of a material impairment. Details of the current report are:

8-K – Sagent Pharmaceuticals, Inc. (0001369786) (Filer)
Filed: 2015-12-31 AccNo: 0001193125-15-418563 Size: 13 KB

Item 2.06: Material Impairments
Filing Date: 2015-12-31T16:18:35-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: